Aadi Bioscience

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$6,179
$5,353
$6,326
$5,959
Gross Profit
5,401
4,701
5,399
5,262
EBITDA
-14,474
-19,462
-17,670
-17,849
EBIT
-14,523
-19,512
-17,714
-17,893
Net Income
-14,583
-18,289
-16,268
-16,302
Net Change In Cash
6,179
5,353
6,326
5,959
Free Cash Flow
-9,698
-20,392
-10,460
-13,049
Cash
41,139
53,780
62,888
68,803
Basic Shares
27,010
26,980
26,965
26,946

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$24,354
$15,216
$1,000
$14,000
Gross Profit
21,545
13,881
724
13,824
EBITDA
-71,764
-56,559
-35,463
-2,652
EBIT
-71,933
-56,718
-35,739
-2,828
Net Income
-65,765
-57,010
-110,090
-3,478
Net Change In Cash
24,354
15,216
1,000
14,000
Cost of Revenue
144,534
4,080
Free Cash Flow
-63,635
-50,084
-22,469
-12,701
Cash
62,888
39,019
148,989
4,455
Basic Shares
26,917
22,511
8,923
2,542

Earnings Calls

Quarter EPS
2024-06-30
-$0.54
2024-03-31
-$0.68
2023-12-31
-$0.60
2023-09-30
-$0.60